Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression (Q44342182)

2 December 2017

title

Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression (English)

1 reference

2 December 2017

0 references

Esther Berrocoso

1

0 references

author name string

Juan-Antonio Mico

series ordinal

2

1 reference

2 December 2017

publication date

3 April 2009

1 reference

The International Journal of Neuropsychopharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

12

1 reference

2 December 2017

issue

8

1 reference

2 December 2017

page(s)

1033-1044

1 reference

Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Opioid peptides inhibit the release of noradrenaline from slices of rat medial preoptic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

A novel augmentation strategy for treating resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Comorbid painful physical symptoms and depression: prevalence, work loss, and help seeking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Association of beta-endorphin with specific clinical symptoms of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Tramadol induces antidepressant-type effects in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Mu receptor binding of some commonly used opioids and their metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Buprenorphine treatment of refractory depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Non-psychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Forced swimming test in mice: a review of antidepressant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Gamma-aminobutyric acidA (GABAA) receptor modulation of morphine inhibition of norepinephrine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Descending control of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

LY248686, a new inhibitor of serotonin and norepinephrine uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Opioid receptor regulation of the release of norepinephrine in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

The antidepressant -like effects of delta-opioid receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Differential effects of age on motor performance in two mouse strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Aversive effects of naltrexone in subjects not dependent on opiates

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Opioid receptor sub-types involved in the control of transmitter release in cortex of the brain of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Differential regulation of 5-hydroxytryptamine release by GABAA and GABAB receptors in midbrain raphe nuclei and forebrain of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

The outcome of physical symptoms with treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Pharmacokinetic/pharmacodynamic modeling of the antinociceptive effects of (+)-tramadol in the rat: role of cytochrome P450 2D activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Modulation of GABA-augmented norepinephrine release in female rat brain slices by opioids and adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

Analgesic and immunomodulatory effects of codeine and codeine 6-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

7 January 2021

Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

7 January 2021

The pharmacogenetics of codeine hypoalgesia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

7 January 2021

Serum beta-endorphin level in patients with depression on fluvoxamine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

7 January 2021

Treatment of refractory major depression with tramadol monotherapy.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

7 January 2021

Some aspects of genetic polymorphism in the biotransformation of antidepressants

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

7 January 2021

Managing weight gain and metabolic issues in patients treated with atypical antipsychotics.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

7 January 2021

Citalopram and Bupropion-SR

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

7 January 2021

Impact of pain on the outcomes of depression treatment: results from the RESPECT trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

7 January 2021

Involvement of the dorsal raphe but not median raphe nucleus in morphine-induced increases in serotonin release in the rat forebrain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

7 January 2021

Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacology

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

7 January 2021

The tail suspension test: a new method for screening antidepressants in mice

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000236

7 January 2021

10.1017/S1461145709000236

Identifiers

DOI

1 reference

2 December 2017

1 reference